AbbVie Inc.
TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES

Abstract:

The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT.sub.2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT.sub.2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT.sub.2C receptor.